Novel Strategy for Oral Peptide Delivery in Incretin-Based Diabetes Treatment

Gut - United Kingdom
doi 10.1136/gutjnl-2019-319146
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Which Incretin-Based Therapy for Type 2 Diabetes?

The Lancet
Medicine
2014English

Novel Strategy for Cystitis Glandularis: Oral Treatment With Cyclooxygenase-2 Inhibitor

International Journal of Urology
Urology
2016English

Incretin-Based Therapy: A Powerful and Promising Weapon in the Treatment of Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Comparison of Efficacy Between Incretin-Based Therapies for Type 2 Diabetes Mellitus

BMC Medicine
Medicine
2012English

Role of Incretin, Incretin Analogues and Dipeptidyl Peptidase 4 Inhibitors in the Pathogenesis and Treatment of Diabetes Mellitus

2011English

Application of Nanocarrier-Based Drug Delivery System in Treatment of Oral Cancer

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2017English

Incorporating Incretin-Based Therapies Into Clinical Practice for Patients With Type 2 Diabetes

Advances in Therapy
MedicinePharmacology
2014English

A Silica-Based pH-sensitive Nanomatrix System Improves the Oral Absorption and Efficacy of Incretin Hormone Glucagon-Like Peptide-1

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2012English

Role of Incretin‐based Therapy in Hospitalized Patients With Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy